Wird geladen...
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort
BACKGROUND: Bimagrumab prevents activity of myostatin and other negative regulators of skeletal muscle mass. This randomized double‐blind, placebo‐controlled study investigated safety, pharmacokinetics (PK), and pharmacodynamics of bimagrumab in healthy older and obese adults. METHODS: A cohort of o...
Gespeichert in:
| Veröffentlicht in: | J Cachexia Sarcopenia Muscle |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749589/ https://ncbi.nlm.nih.gov/pubmed/33264516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12639 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|